These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22792295)

  • 1. The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation.
    Krarup NT; Grarup N; Banasik K; Friedrichsen M; Færch K; Sandholt CH; Jørgensen T; Poulsen P; Witte DR; Vaag A; Sørensen T; Pedersen O; Hansen T
    PLoS One; 2012; 7(7):e40376. PubMed ID: 22792295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of metabolic syndrome and patatin-like phospholipase 3 - rs738409 gene variant in non-alcoholic fatty liver disease among a Chennai-based south Indian population.
    Narayanasamy K; Karthick R; Panneerselvam P; Mohan N; Ramachandran A; Prakash R; Rajaram M
    J Gene Med; 2020 Apr; 22(4):e3160. PubMed ID: 31945251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
    Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
    Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
    Park JH; Cho B; Kwon H; Prilutsky D; Yun JM; Choi HC; Hwang KB; Lee IH; Kim JI; Kong SW
    Liver Int; 2015 Dec; 35(12):2537-46. PubMed ID: 26148225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
    Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
    Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease.
    Bhatt SP; Nigam P; Misra A; Guleria R; Pandey RM; Pasha MA
    Metab Syndr Relat Disord; 2013 Oct; 11(5):329-35. PubMed ID: 23734760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2.
    Zhou Y; Llauradó G; Orešič M; Hyötyläinen T; Orho-Melander M; Yki-Järvinen H
    J Hepatol; 2015 Mar; 62(3):657-63. PubMed ID: 25457209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects.
    Grarup N; Andreasen CH; Andersen MK; Albrechtsen A; Sandbaek A; Lauritzen T; Borch-Johnsen K; Jørgensen T; Schmitz O; Hansen T; Pedersen O
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2294-9. PubMed ID: 18364377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.
    Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
    BMC Med Genet; 2020 Aug; 21(1):163. PubMed ID: 32811452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.
    Hotta K; Yoneda M; Hyogo H; Ochi H; Mizusawa S; Ueno T; Chayama K; Nakajima A; Nakao K; Sekine A
    BMC Med Genet; 2010 Dec; 11():172. PubMed ID: 21176169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes.
    Zaharia OP; Strassburger K; Knebel B; Kupriyanova Y; Karusheva Y; Wolkersdorfer M; Bódis K; Markgraf DF; Burkart V; Hwang JH; Kotzka J; Al-Hasani H; Szendroedi J; Roden M;
    Diabetes Care; 2020 Sep; 43(9):2161-2168. PubMed ID: 32910776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
    Kantartzis K; Peter A; Machicao F; Machann J; Wagner S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
    Diabetes; 2009 Nov; 58(11):2616-23. PubMed ID: 19651814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism rs738409 in PNPLA3 is associated with inherited susceptibility to non-alcoholic fatty liver disease].
    Xu J; Xin YN; Lü WH; Lin ZH; Zhang DD; Zhang M; Dong QJ; Jiang XJ; Xuan SY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):619-23. PubMed ID: 24119744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.
    Zain SM; Mohamed R; Mahadeva S; Cheah PL; Rampal S; Basu RC; Mohamed Z
    Hum Genet; 2012 Jul; 131(7):1145-52. PubMed ID: 22258181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI family heart study.
    Graff M; North KE; Franceschini N; Reiner AP; Feitosa M; Carr JJ; Gordon-Larsen P; Wojczynski MK; Borecki IB
    Int J Obes (Lond); 2013 Mar; 37(3):432-8. PubMed ID: 22546774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant.
    Palmer CN; Maglio C; Pirazzi C; Burza MA; Adiels M; Burch L; Donnelly LA; Colhoun H; Doney AS; Dillon JF; Pearson ER; McCarthy M; Hattersley AT; Frayling T; Morris AD; Peltonen M; Svensson PA; Jacobson P; Borén J; Sjöström L; Carlsson LM; Romeo S
    PLoS One; 2012; 7(6):e39362. PubMed ID: 22724004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes.
    Karamfilova V; Gateva A; Assyov Y; Alexiev A; Savov A; Yaneva N; Ivanova I; Ivanova-Boyanova R; Ivanova R; Vlahova Z; Mateva L; Kamenov Z
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):433-438. PubMed ID: 31826069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans.
    Sevastianova K; Kotronen A; Gastaldelli A; Perttilä J; Hakkarainen A; Lundbom J; Suojanen L; Orho-Melander M; Lundbom N; Ferrannini E; Rissanen A; Olkkonen VM; Yki-Järvinen H
    Am J Clin Nutr; 2011 Jul; 94(1):104-11. PubMed ID: 21525193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PNPLA3 rs738409 associates with alcoholic liver cirrhosis but not with serum levels of IL6, IL10, IL8 or CCL2 in the Russian population.
    Peregud DI; Baronets VY; Lobacheva AS; Ivanov AS; Arisheva OS; Garmash IV; Kobalava ZD; Pirozhkov SV; Terebilina NN
    Ann Hepatol; 2021; 20():100247. PubMed ID: 32871288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.